drugset / Trial / NCT00774111

GSK1349572 Drug Interaction Study With Etravirine

NCT00774111

Phase 1 Completed 16 enrolled GlaxoSmithKline Shionogi · collab
Non-randomizedSingle-groupOpen-label

Summary

A study in healthy volunteers to determine whether there is a drug interaction between GSK1349572 and etravirine

Timeline

Start
2008-10
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dolutegravir Other / unclassified 50 mg
Subject Etravirine Small molecule

Indications

No indication recorded.